RxDoctor Payments Data

Nicholas Gentry, DO

Pain Medicine · Murrells Inlet, SCNPI 1629538954

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 32.9% of the total. Reporting peaked in 2023 at $4,773 and has fallen 66.7% since, to $1,589 in 2025.

$10,679in general payments, 2019–2025

Across 123 payments — averaging $86.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Medtronic$3K
  • Nevro Corp.$1K
  • Abbott$706
  • Spinal Simplicity, LLC$490
  • Curonix LLC$418
  • plus $2K from 8 others

What the payments were for

  • Travel & lodging$4,25740%
  • Food & beverage$5,53752%
  • Education$8858%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,679 in reported general payments places this provider in the 80th percentile of 92 pain medicine providers in South Carolina.

See all pain medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$88,172
Medicare patients
152
Services billed
8,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin31$434
Pregabalin19$387
Methocarbamol15$177
Tizanidine Hcl13$162
Celecoxib12$145
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$68
Cephalexin12$63
Methylprednisolone12$53

Paid to pharmacies, not to this prescriber.

Other pain medicine in Murrells Inlet

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →